Company Filing History:
Years Active: 2018
Title: Chang-Hui Koo: Innovator in Pharmaceutical Synthesis
Introduction
Chang-Hui Koo is a notable inventor based in Ansan-si, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the synthesis of important medicinal compounds. His work focuses on enhancing the purity and yield of drugs used in the treatment of serious health conditions.
Latest Patents
Chang-Hui Koo holds a patent for a synthesis method aimed at improving tenofovir disoproxil fumarate (Teno-DF). This compound is crucial for treating hepatitis B and HIV due to its bioactive properties. The patented method utilizes an ion-exchange resin, specifically Dowex 50W in hydrogen form, to prevent the formation of impurities and byproducts during synthesis. Additionally, the invention includes a method for preparing an oral dissolving film dosage form using the high-purity tenofovir compound as an effective ingredient.
Career Highlights
Chang-Hui Koo is associated with Firson, where he applies his expertise in pharmaceutical synthesis. His innovative approach has led to advancements in drug formulation, contributing to more effective treatment options for patients.
Collaborations
He has collaborated with notable colleagues, including Dong-Jin Kim and Il-Hee Cho, to further enhance the research and development of pharmaceutical products.
Conclusion
Chang-Hui Koo's work exemplifies the importance of innovation in the pharmaceutical industry. His contributions to the synthesis of tenofovir disoproxil fumarate highlight the potential for improved treatment methods for serious diseases.